WA-AMAZON.COM
1.8.2019 12:02:06 CEST | Business Wire | Press release
Amazon (NASDAQ: AMZN) today announced the company’s 65th and 66th renewable energy projects. Amazon’s newest renewable energy project in the EU will be located in Cork, Ireland, and will be the second Amazon Wind Farm in the Republic of Ireland. Once complete, the new Amazon Wind Farm will provide 23.2 megawatts (MW) of renewable capacity, with expected generation of 68,000 megawatt hours (MWh) of clean energy annually. Amazon’s newest renewable energy project in the U.S. will be located in Pittsylvania County, Virginia, and will be the seventh Amazon Solar Farm in the Commonwealth of Virginia. Once complete, the new Amazon Solar Farm will provide 45 megawatts (MW) of renewable capacity and is expected to generate 100,000 megawatt hours (MWh) of clean energy annually. Both projects are expected to begin producing clean energy in 2020 and will supply clean energy to the company’s Amazon Web Services datacenters, which power Amazon and millions of AWS customers globally.
Additionally, Amazon’s investments in renewable energy were recently recognized in the Solar Energy Industries Association’s (SEIA) 2018 Solar Means Business Report , which ranked Amazon #1 in the U.S. for amount of corporate on-site solar installed in 2018, and #2 for total amount of solar installed to date. Amazon’s solar projects in the U.S. have offset the CO2 equivalent of more than 200 million miles of truck deliveries. Globally, Amazon has 66 renewable energy projects – including 51 solar rooftops – that are expected to generate 1,342 MW of renewable capacity and deliver more than 3.9 million MWh of clean energy annually.
“Playing a significant role in helping to reduce the sources of human-induced climate change is an important commitment for Amazon,” said Kara Hurst, Director of Sustainability, Amazon. “Major investments in renewable energy are a critical step to address our carbon footprint globally. We will continue to invest in these projects, and look forward to additional investments this year and beyond.”
“Under the Climate Action Plan, we are committing that 70 percent of Ireland’s electricity will come from renewable sources by 2030. Industry leadership is key to helping us reach this target,” said Richard Bruton, Ireland’s Minister for Communications, Climate Action and Environment. “This project is another example of AWS’s commitment to renewable projects in Ireland, adding clean energy to the grid, and supporting Ireland’s climate commitments. Construction will begin on this project this year and will start contributing to Ireland’s renewable energy capacity by 2020. We look forward to continuing to work with AWS as we strive to make Ireland a leader in the renewable energy space.”
“I applaud Amazon for their continued investment in clean and renewable energy projects in the Commonwealth of Virginia,” said Virginia Senator Mark R. Warner. “This solar energy project in Pittsylvania County will lead to a cleaner environment and more jobs in the community.”
“It’s wonderful to see the announcement of these new projects, which will help bring more renewable energy to the Commonwealth of Virginia where Amazon has already helped bring significant solar energy projects online,” said Virginia Governor Ralph Northam. “Amazon’s new solar farm in Virginia will create jobs and economic development in rural Virginia, and will continue to build upon our role as a leading state for renewable energy in the U.S.”
Beyond investments in wind and solar, Amazon has a long history of commitment to sustainability through innovative programs such as Shipment Zero , Frustration-Free Packaging, Ships in Own Container, investments in the circular economy with the Closed Loop Fund, and numerous other initiatives happening every day by teams across Amazon. Amazon has also implemented the District Energy Project that uses recycled energy to heat and cool more than 3 million square feet of office space. For more information on Amazon’s sustainability initiatives, visit www.amazon.com/sustainability .
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews .
About Amazon Web Services
For 13 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 165 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 66 Availability Zones (AZs) within 21 geographic regions, spanning the U.S., Australia, Brazil, Canada, China, France, Germany, Hong Kong Special Administrative Region, India, Ireland, Japan, Korea, Singapore, Sweden, and the UK. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190801005260/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom